No. 22-339
Pfizer Inc. v. Department of Health and Human Services, et al.
Amici (5)
Experienced Counsel
Tags: advisory-opinion-process anti-kickback-statute criminal-intent healthcare-fraud medical-decision-making medicare mens-rea remuneration rule-of-lenity statutory-interpretation
Latest Conference:
2023-01-06
Question Presented (from Petition)
Whether the AKS is violated only if the person offering the "remuneration * * * to induce" the purchase of federally reimbursed healthcare intends to corrupt the recipient's medical decision-making.
Question Presented (AI Summary)
Whether the Anti-Kickback Statute is violated only if the person offering the remuneration intends to corrupt the recipient's medical decision-making
Docket Entries
2023-01-09
Motion for leave to file amicus brief filed by National Minority Quality Forum GRANTED.
2023-01-09
Petition DENIED.
2022-12-21
DISTRIBUTED for Conference of 1/6/2023.
2022-12-21
Reply of petitioner Pfizer Inc. filed. (Distributed)
2022-12-20
Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner.
2022-12-14
Brief of respondents United States Department of Health and Human Services, et al. in opposition filed.
2022-11-14
Brief amicus curiae of TrialCard Inc. filed.
2022-11-14
Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.
2022-11-14
Motion for leave to file amicus brief filed by National Minority Quality Forum.
2022-11-14
Brief amici curiae of Johnson & Johnson Patient Assistance Foundation, Inc. and Janssen Pharmaceuticals, Inc. filed.
2022-10-24
Motion to extend the time to file a response is granted and the time is extended to and including December 14, 2022.
2022-10-21
Motion to extend the time to file a response from November 14, 2022 to December 14, 2022, submitted to The Clerk.
2022-10-07
Petition for a writ of certiorari filed. (Response due November 14, 2022)
Attorneys
Johnson & Johnson Patient Assistance Foundation, Inc.; Janssen Pharmaceuticals, Inc.
Paul J. Zidlicky — Sidley & Austin, Amicus
National Minority Quality Forum
Pfizer Inc.
Douglas Harry Hallward-Driemeier — Ropes & Gray, LLP, Petitioner
Pharmaceutical Research and Manufacturers of America
Jeffrey S. Bucholtz — King & Spalding LLP, Amicus
TrialCard Inc.
Carter G. Phillips — Sidley Austin LLP, Amicus
United States Department of Health and Human Services, et al.
Elizabeth B. Prelogar — Solicitor General, Respondent